Skip to main navigation

Skip to content

Return to T2 Biosystems Homepage Contact T2 Biosystems

Investor Relations

Overview
Corporate Governance
Press Releases
SEC Filings
Events & Presentations
Annual Reports
Investor FAQ
Stock Information
Email Alerts

Tools

Print Page
RSS Feeds
Email Alerts

Events & Presentations

Webcast
First Quarter 2024 Results Call
Monday, May 06, 2024 4:30 pm EDT

First Quarter 2024 Results Call
Monday, May 06, 2024 4:30 pm EDT
Webcast Presentation

Click here for webcast

Presentations

Date	Documents
04/23/24	Add Files April 2024 Investor Presentation 1 MB

Upcoming Events

First Quarter 2024 Results Call

Monday, May 06, 2024 4:30 pm EDT

Click here for webcast

Past Events

Business Update Call

Wednesday, March 20, 2024 8:30 am EDT

Fourth Quarter and Full Year 2023 Financial Results Call and Business Update

Thursday, February 15, 2024 4:30 pm EST

Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Thursday, November 16, 2023 8:00 am EST

Preliminary Third Quarter 2023 Financial Results Call and Business Update

Thursday, October 12, 2023 4:30 pm EDT

Gilmartin Group Emerging Growth Showcase

Thursday, September 21, 2023 10:30 am EDT

Sidoti Micro Cap Conference

Wednesday, August 16, 2023 10:00 am EDT

Canaccord Genuity 43rd Annual Growth Conference

Wednesday, August 09, 2023 1:00 pm EDT

Second Quarter 2023 Results Conference Call

Monday, August 07, 2023 4:30 pm EDT

First Quarter 2023 Results Conference Call

Tuesday, May 23, 2023 8:30 am EDT

Fourth Quarter 2022 Results Conference Call

Monday, March 13, 2023 4:30 pm EDT

T2 Biosystems OVERVIEW

T2 Biosystems, an emerging leader in the field of in vitro diagnostics, is dedicated to saving lives and reducing the cost of healthcare by empowering clinicians to effectively treat patients faster than ever before. T2 Biosystems is focused on addressing critical unmet needs in healthcare starting with sepsis, one of the deadliest and most expensive conditions in hospitals today.

The T2Dx Instrument and T2Candida Panel have received marketing authorization from the U.S. Food and Drug Administration. All other T2 Biosystems products are considered investigational and for research use only.

T2 Biosystems®, T2MR®, T2Candida®, T2Dx®, and T2 Bio® are registered trademarks of T2 Biosystems, Inc. T2HemoStat™, T2Plex™, and T2Bacteria™ are trademarks of T2 Biosystems, Inc.

© 2024 T2 Biosystems, Inc.

JOIN IN ON TWITTER

Sitemap

T2Direct Diagnostics
T2MR Technology
Pipeline
Our Company
Terms of Use & Privacy Policy
Conflict Mineral Report

Investors
T2Blog
Technical Support
Careers
Contact Us
Standard Terms & Conditions

Follow Us on Social

LinkedIn
Twitter